Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abciximab in Diabetic PCI with High Platelet Reactivity
NCT01475552Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Sep 2010
- Primary completion
- Sep 2011
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of abciximab in coronary artery disease (CAD), sponsored by Seoul National University Bundang Hospital. Started Sep 2010; status: completed.
02
Drugs
abciximab
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01475552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475552.